Product & Industry News
Page 1 to 16 of 20 |     NEXT PAGE >
PhoreMost enters collaboration with Otsuka
PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical.

Read More

Carterra Closes Financing Round for LSA Platform
Carterra Closes Financing Round for Continued Growth of the LSA Platform for Next Generation Antibody Discovery.

Read More

Advanced BioMatrix Acquires HyStem from Lineage Cell Therapeutics
Advanced BioMatrix has acquired the HyStem line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan.

Read More

Evonetix collaborates with imec to scale-up chip-based technology
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform.

Read More

Exosomics implements NanoFCM’s NanoAnalyzer
Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility to provide advanced extracellular vesicles-focused analytical services.

Read More

Grey Wolf completes financing to accelerate development of ERAP2 therapies
Grey Wolf Therapeutics completes £2.5 million ($3.3 million) Series A2 financing to accelerate development of therapies targeting ERAP2. Grey Wolf targets ERAP antigen presentation pathways with the aim of 'illuminating' non-responsive tumors for attack and destruction by the immune system.

Read More

Enterprise Therapeutics publishes paper on novel cystic fibrosis approach
Enterprise Therapeutics publishes paper on novel therapeutic approach for treatment of all cystic fibrosis patients.

Read More

RenaSci bolsters kidney disease and fibrosis capabilities with senior appointment
Leading in vivo pharmacology and consultancy services firm RenaSci, part of the Sygnature Group, have bolstered their Kidney Disease and Fibrosis capabilities with the appointment of Dr Wioletta Pijacka.

Read More

Arctoris Ltd Successfully Moves into its New Global Headquarters in Oxford, UK
State-of-the art facility is home to the company's next-generation, fully automated platform for drug discovery.

Read More

Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO
The financing will accelerate the development of first-in-class therapies in autoimmune disease and immuno-oncology.

Read More

The most discussed and shared scientific research of 2019
Climate crisis, artificial intelligence, and vaccines top the list of 2019’s most discussed research.

Read More

TTP Labtech Announces Company Name Change to SPT Labtech
TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, has announced its corporate name change to SPT Labtech effective from January 6, 2020.

Read More

Inceptua Appoints New CEO
Inceptua announced today that Stefan Fraenkel has been appointed CEO effective 1 January 2020. Alan Raffensperger is appointed Executive Vice-Chairman of the Inceptua Group.

Read More

Horizon Discovery introduces predesigned synthetic sgRNAs to streamline CRISPR gene editing workflows
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation technologies, today announced the addition of predesigned synthetic single guide RNA (sgRNA) to its product range.

Read More

Spotlight on Abzena's Developability Platform
Spotlight on Abzena's Developability Platform during Antibody Engineering & Therapeutics 2019.

Read More

IONTAS antibody enters clinical trial
IONTAS antibody enters clinical trial for use in the treatment of B cell Acute Lymphoblastic Leukemia.

Read More

Product & Industry News
Page 1 to 16 of 20 |     NEXT PAGE >